PSY36 Economic Evaluation of Pegvisomant for Active Acromegaly Patients who Failed Available Therapies in Brazil – Public Health Care System Perspective
Year: 2012
Type: conference-abstract
Source: Value in Health
Authors: R.K. Fujii, J.F. Mould, R.A. Fernandes, F. Furlan, D.F. Manfrin
Institution: Pfizer (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2079524451